Clarisyn
The evidence is scattered across papers and databases. The answer shouldn't be.
Clarisyn runs multi-agent analysis across published literature and experimental data, and returns one decision-ready report.
When does Clarisyn actually help?
"What does the evidence actually say?"
"Has this mechanism been studied before?"
"Which cell lines are most dependent on this target?"
"Why do these findings disagree?"
"Is this target worth pursuing?"
"Will this scaffold bind the pocket, and how confident should I be?"
"Does the data support that conclusion?"
"What does the literature suggest we do next?"
Different people. Same moment.
That's when you open Clarisyn.
Ask any biomedical question.
Clarisyn answers it from every angle the question needs, across published literature and experimental data.
Multi-agent analysis in progress.
Automated
Multi-agent analysis across literature and data.
Expert review
A domain expert validates the findings before delivery.
Your decision-ready structured report. In three layers.
Intelligence Report, highlighting the key insights and actionable takeaways.CYP3A4-mediated inhibition at clinical exposure levels presents a low but non-negligible DDI risk. Based on available in vitro and in vivo data, dose adjustment guidance for co-administered substrates is warranted prior to Phase I initiation.Agent consensus: 2 of 3 agents flagged DDI risk as clinically actionable. 1 agent rated risk as low-moderate pending in vivo confirmation.
Reasoning
Reasoning, scoring, and decision steps are shown in full for transparency.
Biological rationale and competitive intensity weighted across 7 criteria.
Each indication scored on a 1–5 scale per criterion, summed into a final weighted score.
Process
Intermediate steps are logged for full process transparency.
All reasoning steps are documented in a single file, with each agent's process clearly separated.
This analysis was built on 49 curated sources, synthesized across 200+ datasets spanning preclinical and clinical literature.
What sets Clarisyn apart?
Every response draws from millions of academic papers, clinical trials, chemical databases, and protein structures.
General AI searches the web. Clarisyn searches the science. Structured, layered output shaped with scientists, built for scientists.
Is the hepatotoxicity signal observed in rats clinically relevant in humans?
Every question is investigated by specialised agents with different scientific roles, searching the literature, querying data, running analyses and verifying claims. They compare findings, challenge conflicts and reconcile the evidence into one answer.
AGENTS CROSS-CHECK
Clarisyn works across published literature and computational biology: dependency and viability datasets, expression signatures, structure prediction, docking. The question shapes the sources, not the other way round.
Reports can be shared, annotated, and discussed with your team. When a second opinion matters more than a second look, an independent expert can review it: professors, MDs, PhD researchers, without leaving the platform.
Can we rerun this with updated tox data?
Clarisyn doesn't stop at your question. It maps the full picture, with follow-up questions already answered.